199 related articles for article (PubMed ID: 25253971)
1. Hepatoid adenocarcinoma of the colon in a patient with inflammatory bowel disease.
Chen Y; Schaeffer DF; Yoshida EM
World J Gastroenterol; 2014 Sep; 20(35):12657-61. PubMed ID: 25253971
[TBL] [Abstract][Full Text] [Related]
2. Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.
Ochiai T; Masuda T; Yagi M; Kasai R; Furuyama T; Tsukamoto K; Ito H; Igari K; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
Int Surg; 2012; 97(1):6-13. PubMed ID: 23101994
[TBL] [Abstract][Full Text] [Related]
3. Synchronous quintuple primary gastrointestinal tract malignancies: Case report.
Kim SH; Park BS; Kim HS; Kim JH
World J Gastroenterol; 2017 Jan; 23(1):173-177. PubMed ID: 28104993
[TBL] [Abstract][Full Text] [Related]
4. Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma.
Gopaldas R; Kunasani R; Plymyer MR; Bloch RS
Surg Oncol; 2005 Jul; 14(1):11-25. PubMed ID: 15777886
[TBL] [Abstract][Full Text] [Related]
5. Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literature.
Takada S; Hoshino Y; Ito H; Masugi Y; Terauchi T; Endo K; Kimata M; Furukawa J; Shinozaki H; Kobayashi K; Ogata Y
Jpn J Clin Oncol; 2015 Mar; 45(3):286-90. PubMed ID: 25489005
[TBL] [Abstract][Full Text] [Related]
6. [A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].
Ojima E; Nakano T; Kanamoto A; Sasaki S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1962-4. PubMed ID: 24393980
[TBL] [Abstract][Full Text] [Related]
7. Case records of the Massachusetts General Hospital. Case 19-2010. A 35-year-old man with adenocarcinoma of the cecum.
Ryan DP; Engelman JA; Ferrone CR; Sahani DV; Lisovsky M
N Engl J Med; 2010 Jun; 362(25):2411-9. PubMed ID: 20573930
[No Abstract] [Full Text] [Related]
8. [Individualized therapy of synchronous ovarian and colon cancers with lymph].
Deme D; Bishr AM; Nizar J; Telekes A
Orv Hetil; 2015 Jun; 156(23):939-43. PubMed ID: 26027602
[TBL] [Abstract][Full Text] [Related]
9. Conversion treatment of hepatic metastases of colon adenocarcinoma by bevacizumab and FOLFOX.
Leite D; Kater FR
Anticancer Drugs; 2011 Jun; 22 Suppl 2():S1-7. PubMed ID: 21768791
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor.
Cetin B; Kaplan MA; Berk V; Tufan G; Benekli M; Isikdogan A; Ozkan M; Coskun U; Buyukberber S
Jpn J Clin Oncol; 2013 Jan; 43(1):28-32. PubMed ID: 23107836
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
de Gramont A; Van Cutsem E; Schmoll HJ; Tabernero J; Clarke S; Moore MJ; Cunningham D; Cartwright TH; Hecht JR; Rivera F; Im SA; Bodoky G; Salazar R; Maindrault-Goebel F; Shacham-Shmueli E; Bajetta E; Makrutzki M; Shang A; André T; Hoff PM
Lancet Oncol; 2012 Dec; 13(12):1225-33. PubMed ID: 23168362
[TBL] [Abstract][Full Text] [Related]
12. [Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery].
Abbrederis K; Kremer M; Schuhmacher C
Chirurg; 2008 Apr; 79(4):351-5. PubMed ID: 17453167
[TBL] [Abstract][Full Text] [Related]
13. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
14. Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.
Shitara K; Yuki S; Yamazaki K; Naito Y; Fukushima H; Komatsu Y; Yasui H; Takano T; Muro K
J Cancer Res Clin Oncol; 2013 Apr; 139(4):595-603. PubMed ID: 23250506
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer.
Spigel DR; Bendell JC; McCleod M; Shipley DL; Arrowsmith E; Barnes EK; Infante JR; Burris HA; Greco FA; Hainsworth JD
Clin Colorectal Cancer; 2012 Mar; 11(1):45-52. PubMed ID: 21840771
[TBL] [Abstract][Full Text] [Related]
16. How can we treat a patient with liver cirrhosis (hepatitis C virus), hepatocellular carcinoma, and synchronous colon cancer?
Antoniou E; Mantas D; Paraskeva P; Dimitroulis D; Smyrnis A; Nikitakis N; Labadariou A; Tsavaris N; Vernicos P; Kostakis A
Transplant Proc; 2012 Nov; 44(9):2745-7. PubMed ID: 23146511
[TBL] [Abstract][Full Text] [Related]
17. Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting.
Moreau LC; Rajan R; Thirlwell MP; Alcindor T
Anticancer Res; 2013 Apr; 33(4):1765-8. PubMed ID: 23564831
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis.
Buchler T; Pavlik T; Melichar B; Bortlicek Z; Usiakova Z; Dusek L; Kiss I; Kohoutek M; Benesova V; Vyzula R; Abrahamova J; Obermannova R
BMC Cancer; 2014 May; 14():323. PubMed ID: 24884897
[TBL] [Abstract][Full Text] [Related]
19. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in a liver graft recipient: a case report.
Horvath P; Königsrainer I; Nadalin S; Beckert S; Löffler M; Königsrainer A
Ann Transplant; 2013 Apr; 18():182-6. PubMed ID: 23792519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
